Medical and Science
Understanding AI and ML and potential applications for Medical Affairs

Due to shifting healthcare provider (HCP) interaction paradigms, Medical Affairs teams are facing unprecedented demand for frictionless access to highly personalised, unbiased content and medical information. At the same time, Medical Affairs has the responsibility to ensure the accuracy of all medical communications, enhance customer interactions and improve efficiencies.
MAPS (Medical Affairs Professionals Society) developed the following webinar to help medical teams understand the following:
- Latest technologies; Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), and Natural Language Understanding (NLU).
- Potential of these technologies to increase efficiencies, enhance effectiveness and potentially reduce compliance risk.
MAPS is the premier non-profit global society of Medical Affairs professionals across a spectrum of fields, experience, and locales. With their non-profit status, MAPS is able to reinvest all revenue back into the society, which ensures their ability to create valuable programs and resources that support the Medical Affairs community.
News - MedTech & Diagnostics
Hearts4heart takes aim at health insurers leaving patients to pay the price
Persistent advocacy by patient groups has prompted the Medical Services Advisory Committee (MSAC) to review the funding gaps for pulsed […]
MoreNews - MedTech & Diagnostics
Queensland first: Private hospitals deploy Abbott’s PFA in atrial fibrillation
More Australians living with atrial fibrillation (AF) are gaining access to one of the latest advances in heart-rhythm treatment, with […]
MoreNews - Pharmaceuticals
Five years of HTA reform talk, now comes the $47 billion question
Medicines Australia has put a $47 billion price tag on what it says Australia must invest to improve equitable access […]
MoreNews - Pharmaceuticals
New MFN deals raise the stakes for Australia’s delayed HTA reform
Four months after the US Trump administration concluded what was expected to be the final tranche of drug-pricing agreements with […]
More